NGEN News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-13 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-07-02 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-06-01 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-05-26 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-05-22 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-05-18 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-05-15 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-04-27 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-03-13 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-02-13 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-02-10 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |
| 2026-01-08 | Foreign issuer report | SEC filing | NERVGEN PHARMA CORP. filed Form 6-K | NERVGEN PHARMA CORP. filed Form 6-K. |